229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
42.11%
Positive revenue growth while VUZI is negative. John Neff might see a notable competitive edge here.
1933.33%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
96.90%
EBIT growth above 1.5x VUZI's 11.13%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
96.90%
Operating income growth above 1.5x VUZI's 10.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
120.77%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
120.00%
EPS growth above 1.5x VUZI's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
120.00%
Diluted EPS growth above 1.5x VUZI's 9.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
2.64%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
4.64%
Diluted share count expanding well above VUZI's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-238.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-74.29%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-37.17%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-53.20%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-22.32%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-70.53%
Negative 10Y OCF/share CAGR while VUZI stands at 60.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
91.31%
5Y OCF/share CAGR above 1.5x VUZI's 51.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-121.65%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-76.99%
Negative 10Y net income/share CAGR while VUZI is at 33.50%. Joel Greenblatt sees a major red flag in long-term profit erosion.
104.15%
5Y net income/share CAGR above 1.5x VUZI's 14.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-40.37%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.52%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
29.93%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
105.39%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while VUZI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
44.44%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-52.38%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.41%
Asset growth at 75-90% of VUZI's 3.19%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
-1.89%
We have a declining book value while VUZI shows 2.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.93%
We have some new debt while VUZI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.98%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.68%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
